Duality Advisers, LP Natera, Inc. Transaction History

Duality Advisers, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 27, 2023	BUY	$36.57 - $58.29 $1.23 Million - $1.96 Million	33,650 New	33,650 $1.87 Million
Q1 2022 May 09, 2022	SELL	$30.32 - $91.33 $198,868 - $599,033	-6,559 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$86.26 - $119.0 $565,779 - $780,521	6,559 New	6,559 $613,000
Q3 2021 Nov 08, 2021	SELL	$100.17 - $126.36 $1.66 Million - $2.1 Million	-16,610 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$86.05 - $119.72 $74,347 - $103,438	864 Added 5.49%	16,610 $1.89 Million
Q1 2021 May 13, 2021	BUY	$91.47 - $124.36 $1.44 Million - $1.96 Million	15,746 New	15,746 $1.6 Million

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.